XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
A
A

Amgen


뉴스

Amid an uncertain landscape, high quality may offer stable ground

LIVE MARKETS-Amid an uncertain landscape, high quality may offer stable ground Dow and S&P 500 climb, Nasdaq off ~0.2% Financials lead S&P 500 sector gainers; Comm Svcs weakest group Euro STOXX 600 index up ~0.5% Dollar slips; gold, crude both off ~1%; bitcoin off >2% U.S. 10-Year Treasury yield dips to ~3.82% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
A
G
K
N
V
G
U
U
F
I
S
U
A
G
B

Amgen sues Samsung biotech unit over bone drug copies

Amgen sues Samsung biotech unit over bone drug copies By Blake Brittain Aug 13 (Reuters) - Amgen AMGN.O has sued Samsung's biologics unit 207940.KS in New Jersey federal court over its proposed biosimilar versions of Amgen's blockbuster bone drugs Prolia and Xgeva. Amgen's lawsuit against Samsung Bioepis, filed on Monday, said the biosimilars would infringe 34 patents covering Amgen drugs.
A

Amgen To Open New Site In Hyderabad, India

BRIEF-Amgen To Open New Site In Hyderabad, India Aug 9 (Reuters) - Amgen Inc AMGN.O : AMGEN TO OPEN NEW SITE IN HYDERABAD, INDIA Source text for Eikon: ID:nPreCsdBha Further company coverage: AMGN.O
A

Tech surge, BOJ's dovish comments boost Wall Street

US STOCKS-Tech surge, BOJ's dovish comments boost Wall Street For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps on FY revenue forecast raise Charles River slides after cutting FY forecasts Indexes up: S&P 500 1.36%, Nasdaq 1.64%, Dow 0.9% Updated at 11:22 a.m.
A
A
T
U
U
U
U
D

U.S. STOCKS Abbott Laboratories, Medtronic, Axon

BUZZ-U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week which partly sparked heavy volatility in global markets.
A
A
C
F
I
T
U
U
L

Wall St charges ahead as Big Tech relief rally continues

US STOCKS-Wall St charges ahead as Big Tech relief rally continues For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast Charles River slides after cutting FY forecasts Indexes up: S&P 500 1.2%, Nasdaq 1.7%, Dow 0.7% Updated at 9:35 a.m.
A
A
N
U
U
U
U
D

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Wall St set to open higher as Big Tech buying continues

US STOCKS-Wall St set to open higher as Big Tech buying continues For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast CVS Health down after cutting FY profit forecast Futures up: S&P 500 1%, Nasdaq 1.18%, Dow 0.72% Updated at 8:25 a.m.
A
A
M
N
U
W
U
U
U
D

U.S. STOCKS Walt Disney, SpringWorks, Shopify

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, with sentiment also getting a boost from cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
F
T
U
L
S

Futures advance as Big Tech continues to recover

US STOCKS-Futures advance as Big Tech continues to recover For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast CVS Health down after cutting FY profit forecast Futures up: Dow 0.8%, S&P 1.2%, Nasdaq 1.5% Updated at 7:05 a.m.
A
A
M
N
U
W
U
U
U
D

Futures rally as Big Tech extends recovery

US STOCKS-Futures rally as Big Tech extends recovery For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Futures up: S&P 500 1.05%, Nasdaq 1.21%, Dow 0.79% Aug 7 (Reuters) - U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, with sentiment also getting a boost from cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
B
U
U
U
U
D
A

Amgen falls as Q2 profit slips

BUZZ-Amgen falls as Q2 profit slips ** Drugmaker Amgen's AMGN.O shares fall 4% to $315.51 premarket ** Co late on Tuesday reported Q2 adjusted profit of $4.97 per share, largely in-line with average analyst estimate -LSEG data ** Adj. profit slipped 1% year-over-year hurt by higher expenses, including costs related to development of its experimenta
A

U.S. Amgen, Atkore, MoneyLion

U.S. RESEARCH ROUNDUP-Amgen, Atkore, MoneyLion Aug 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Atkore and MoneyLion on Wednesday. HIGHLIGHTS * Amgen Inc AMGN.O : RBC raises target price to $362 from $332 * Atkore Inc ATKR.N : RBC cuts to sector perform from outperform * MoneyLion ML.N : Needham cuts target price to $70 from $100 * Progyny Inc PGNY.O : BTIG cuts to neutral from buy * Truecar Inc TRUE.O :
A
A
A
B
B

Amgen Inc reports results for the quarter ended in June - Earnings Summary

Amgen Inc reports results for the quarter ended in June - Earnings Summary Amgen Inc AMGN.OQ reported quarterly adjusted earnings of $4.97​​ per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of $5.00. The mean expectation of twenty two analysts for the quarter was for earnings of $5.01 per share.
A

Amgen falls on downbeat second-quarter profit

BUZZ-Amgen falls on downbeat second-quarter profit ** Shares of drugmaker Amgen AMGN.O fall ~1.8% to $322.99 in after-market trade ** AMGN reports Q2 adj. profit of $4.97/shr vs analysts' average est. of $5/shr - LSEG ** Says quarterly profit slipped 1% due to higher expenses ** Company's quarterly revenue of $8.39 bln beats analysts' average expectation of $8.37 bln ** AMGN raises the lower end of its 2024 revenue outlook to a range of $32.8 bln to $33.8 bln from a previous low end forecast of
A

Amgen quarterly profit slips, obesity data on track for late 2024

UPDATE 2-Amgen quarterly profit slips, obesity data on track for late 2024 Adds analyst comment paragraph 4, company comment paragraph 10; updates share price By Deena Beasley Aug 6 (Reuters) - Amgen AMGN.O on Tuesday said its second-quarter profit slipped 1% as higher expenses, including costs related to development of its experimental obesity drug MariTide, offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics.
A

Amgen second quarter profit dips, sales rise 20%

Amgen second quarter profit dips, sales rise 20% By Deena Beasley Aug 6 (Reuters) - Amgen AMGN.O on Tuesday said its second-quarter profit slipped 1% as higher expenses offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. Amgen reported adjusted earnings of $4.97 per share, which was just short of the average analyst estimate of $5.00, according to LSEG data.
A

U.S. STOCKS IDEXX, Amgen, Airbnb

BUZZ-U.S. STOCKS ON THE MOVE-IDEXX, Amgen, Airbnb Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
I
U
U
F
M
R
U
V
M

PREVIEW: Amgen shares climb with results on tap

BUZZ-PREVIEW: Amgen shares climb with results on tap ** Amgen AMGN.O shares up 1.8% at $331.09 ahead of Q2 results due after the closing bell amid broad market recovery from three-day selloff ** The biotech company is expected to post EPS of $5.01 on revenue of $8.33 bln, per LSEG data, vs yr-ago results of $5.00 in EPS and $6.99 bln in revenue **
A
U

Rollercoaster markets, Nikkei rebounds 10%

MORNING BID AMERICAS-Rollercoaster markets, Nikkei rebounds 10% A look at the day ahead in U.S. and global markets from Mike Dolan The speed and scale of Tuesday's 10% Tokyo bounce after its worst day in 37 years suggests the wild global market swings of the past week are more rooted in speculative churn than economic fright. While that's only partly reassuring - as persistent market turbulence can itself sap economic activity - there's good reason to believe a slowing U.S.
A
C
N
U
W
J
U
U
U
F
F
D
I
J
M
S
B



조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.